• On sale!
  • Out-of-Stock
search

IRIDINA DUE * COLL 10FL0,5ML0,05

  • Montefarmaco OTC S.p.A.
  • 026630032
Iridina Due is a drug based on the active ingredient naphazoline hydrochloride (FU), belonging to the category of Decongestants and specifically Sympathomimetics used as decongestants. Iridina Due can be prescribed with OTC Recipe - self-medication. Irritation, burning, redness of the eye, with excessive tearing, and sensitivity to light.
info_outline View product sheet
Final Price €9.90

Volume discounts

Quantity Unit discount You Save
2 10% €1.98
5 20% €9.90
10 35% €34.65
error Out-of-Stock

Notify me when available

  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

Montefarmaco OTC S.p.A.

Discover all products

IRIDINA DUE * COLL 10FL0,5ML0,05

Therapeutic indications

Irritation, burning, redness of the eye, with excessive tearing, and sensitivity to light.

Dosage and method of use

When you feel the burning sensation, squeeze one or two drops of eye drops into the inner corner of each eye, tilting your head back. Strictly adhere to the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, can give rise to serious systemic effects.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. The product should not be used in patients with glaucoma or other eye diseases. Contraindicated in children under the age of ten.

Side effects

The use of the product can sometimes cause pupillary dilation, systemic absorption effects (hypertension, heart disease, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case, the treatment must be interrupted and the doctor consulted so that, if necessary, a suitable therapy can be instituted.

Special warnings

In case of persistence or aggravation of symptoms after drinking treatment period, consult your doctor, in any case, the product should not be used for more than 4 consecutive days. If you have the appearance of side effects in a period of less than 4 days, stop the therapy and consult your doctor. Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require the attention of the doctor. Although the product has poor serum absorption, it should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders and hyperglycemia (Diabetes).

Pregnancy and breastfeeding

There are no restrictions on use during pregnancy and lactation.

Expiration and retention

Store at a temperature not exceeding 30 ° C. The product does not contain preservatives: the single-dose container, once opened, must be thrown away after use, even if used only partially.

Interactions with other drugs

The product should be used with caution in case of treatment with antidepressant drugs.

Overdose

In case of overdose due to accidental oral administration, there may be manifestations of depression in the central nervous system with phenomena of bradypnea, cold sensation in the skin, drowsiness, tachycardia, sweating, and mental confusion.

Active principles

1 ml of eye drops, solution contains: 0.5 mg naphazoline hydrochloride For a full list of excipients, see section 6.1.

Excipients

Sodium chloride, Sodium dihydrogen phosphate dihydrate, Sodium hydroxide, Sodium hyaluronate, Distilled water of Hamamelis, Distilled water of Chamomile, Water for injections.

026630032

Data sheet

Packaging
0.5 mg / ml eye drops solution single-dose containers 0.5 ml
Product Type
HUMAN DRUG
ATC code
S01GA01
ATC description
Nafazoline
Therapeutic Group
Decongestants
Active principle
naphazoline hydrochloride (FU)
Class
C.
Pharmaceutical form
eye drops
Type of Administration
ophthalmic
Container
pipette / single-dose containers
Quantity
1 pipette / single-dose container
Capacity
0.5 milliliters
Quantity of the Active Ingredient
, 25MG
Recipe required
OTC - self-medication medicine
chat Comments (0)
Fast Order